REG - Oxford Biomedica PLC - Grant of options <Origin Href="QuoteRef">OXB.L</Origin>

Oxford BioMedicaAnnouncement

08/11/2016 18:15

RNS Number : 6769O
Oxford Biomedica PLC
08 November 2016
8 November 2016
Oncimmune Holdings plc
("Oncimmune" or the "Company")
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PDMR AND PERSONS CLOSELY ASSOCIATED WITH THEM
Oncimmune Holdings plc (AIM: ONC.L), a leading early cancer detection company developing and commercialising its proprietaryEarlyCDTplatform technology, today announces that on 8 November 2016, options over ordinary shares of the Company were awarded to certain Directors and certain PDMRs under the Company's 2016 Share Option Plan (an amalgamation of the Company's 2005 and 2007 Share Option Plans) as follows.
Name
Position
Number of share options awarded 
Option exercise price per share (pence)
Percentage of issued share capital (%)
Meinhard Schmidt
Non-executive Chairman
120,370
108
0.236
Geoffrey Hamilton-Fairley
Chief Executive Officer
528,273
1
1.035


119,875
108
0.235
Andrew Millet
Chief Financial Officer 
92,593
108
0.181
Andrea Murray 
Chief Operational Scientist 
41,667
108
0.082
Maarten Brusse
Chief Commercial Officer 
74,074
108
0.145
The options are subject to the rules of the 2016 Share Option Plan and vest in five equal annual parts, the first fifth vesting on 7 November 2017 and each year thereafter for a further four years, subject to continued employment. Unless otherwise indicated in the table above, the options are exercisable at 108 pence, being the mid-market closing price of the Company's ordinary shares on 7 November 2016
For further information:
Oncimmune Holdings plc
Geoffrey Hamilton-Fairley, Chief Executive Officer
contact@oncimmune.co.uk
Zeus Capital Limited (Nominated Adviser and Broker)
Phil Walker, Giles Balleny, Dominic Wilson
+44 (0) 203 829 5000
Media enquiries:
Consilium Strategic Communications
Chris Gardner, Mary-Jane Elliott, Matthew Neal, Lindsey Neville
oncimmune@consilium-comms.com
+44 (0) 20 3709 5708
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Meinhard Schmidt
2
Reason for the notification

a)

Position/status
Non-Executive Chairman, Director
b)
Initial notification/Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Oncimmune Holdings plc
b)
LEI
N/A
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code

options over 1p ordinary shares - 2016 Share Option Plan 
ISIN GB00BYQ94H38
b)
Nature of the transaction
Grant of options over ordinary shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
N/A
120,370
d)
Aggregated information
Price(s)
Volume(s)
N/A
120,370
e)
Date of the transaction
8 November 2016
f)
Place of the transaction
N/A
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Geoffrey Hamilton-Fairley
2
Reason for the notification

a)

Position/status
Chief Executive Officer
b)
Initial notification/Amendment
Initial Notification 
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Oncimmune Holdings Plc 
b)
LEI
N/A
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code

options over 1p ordinary shares - 2016 Share Option Plan
ISIN GB00BYQ94H38
b)
Nature of the transaction
Grant of options over ordinary shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
N/A
528,273
N/A
119.875
d)
Aggregated information
Price(s)
Volume(s)
 N/A
 648,148
e)
Date of the transaction
8 November 2016
f)
Place of the transaction
N/A
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Andrew Millet
2
Reason for the notification

a)

Position/status
Chief Financial Officer
b)
Initial notification/Amendment
Initial Notification 
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Oncimmune Holdings Plc 
b)
LEI
N/A
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code

options over 1p ordinary shares - 2016 Share Option Plan
ISIN GB00BYQ94H38
b)
Nature of the transaction
Grant of options over ordinary shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
N/A
92,593


d)
Aggregated information
Price(s)
Volume(s)
 N/A
 92,593
e)
Date of the transaction
8 November 2016
f)
Place of the transaction
N/A
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Andrea Murray 
2
Reason for the notification

a)

Position/status
Chief Operational Scientist and PDMR
b)
Initial notification/Amendment
Initial Notification 
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Oncimmune Holdings Plc 
b)
LEI
N/A
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code

options over 1p ordinary shares - 2016 Share Option Plan
ISIN GB00BYQ94H38
b)
Nature of the transaction
Grant of options over ordinary shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
N/A
41,667


d)
Aggregated information
Price(s)
Volume(s)
 N/A
 41,667
e)
Date of the transaction
8 November 2016
f)
Place of the transaction
N/A
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Maarten Brusse
2
Reason for the notification

a)

Position/status
Chief Commercial Officer and PDMR
b)
Initial notification/Amendment
Initial Notification 
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Oncimmune Holdings Plc 
b)
LEI
N/A
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code

options over 1p ordinary shares - 2016 Share Option Plan
ISIN GB00BYQ94H38
b)
Nature of the transaction
Grant of options over ordinary shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
N/A
74,074


d)
Aggregated information
Price(s)
Volume(s)
 N/A
 74,074
e)
Date of the transaction
8 November 2016
f)
Place of the transaction
N/A

This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHBIBDBGBGBGLI